Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hadewych J.M ter Hofstede"'
Autor:
Rob Vriesendorp, Peter P. Koopmans, Clemens Richter, Hadewych J.M. ter Hofstede, David M. Burger, Chris H. H. Ten Napel, Herman G. Sprenger
Publikováno v:
Pharmacology & Pharmacy. :90-96
Antiretroviral therapy in HIV patients is known for its negative effect on the cardiovascular system. One of the major adverse events in patients on lopinavir is increasing lipids. Hyperlipidaemia together with chronic inflammation by HIV-infection i
Autor:
Nurcan Caliskan‐Yassen, Hadewych J.M. ter Hofstede, David M. Burger, Lara Dawood, Eleonora W. J. van Ewijk-Beneken Kolmer, Peter P. Koopmans, Marga J.A. de Graaff-Teulen, Manon J. van der Lee
Publikováno v:
Clinical Pharmacology and Therapeutics, 80, 159-68
Clinical Pharmacology and Therapeutics, 80, 2, pp. 159-68
Clinical Pharmacology and Therapeutics, 80, 2, pp. 159-68
Contains fulltext : 50676.pdf (Publisher’s version ) (Closed access) BACKGROUND: Limited data are available about the effect of lopinavir and low-dose ritonavir on glucuronidation. Lamotrigine undergoes glucuronidation. We studied the effect of lop
Publikováno v:
Journal of Clinical Virology, 29, 44-50
Journal of Clinical Virology, 29, 1, pp. 44-50
Journal of Clinical Virology, 29, 1, pp. 44-50
Contains fulltext : 57752.pdf (Publisher’s version ) (Closed access) BACKGROUND: Nucleoside reverse transcriptase inhibitors (NRTIs) used in antiretroviral therapy may cause mitochondrial toxicity. Mitochondrial dysfunction leads to disturbance of
Autor:
Patricia W.H Hugen, David M Burger, Hadewych J.M ter Hofstede, Peter P Koopmans, Michael Stek, Yechiel A Hekster, Peter Reiss, Joep M.A Lange
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes. :236-245
Autor:
Marjolein Bosch, David M. Burger, Hadewych J.M. ter Hofstede, Jacqueline A. H. Droste, Eva P Muro, Wil M. V. Dolmans
Publikováno v:
JAIDS : Journal of Acquired Immune Deficiency Syndromes, 39, 4, pp. 419-21
JAIDS : Journal of Acquired Immune Deficiency Syndromes, 39, 419-21
JAIDS : Journal of Acquired Immune Deficiency Syndromes, 39, 419-21
Contains fulltext : 48952.pdf (Publisher’s version ) (Closed access) BACKGROUND: Single-dose nevirapine is a highly cost-effective strategy to reduce perinatal HIV-1 transmission. Its major disadvantage is the selection of nevirapine resistance in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c14c8236ebc9901540e411ca6c597b
https://hdl.handle.net/2066/48952
https://hdl.handle.net/2066/48952
Autor:
Rob Schuurman, Peter P. Koopmans, Y.A. Hekster, Kees Brinkman, David M. Burger, Patricia Wh Hugen, Hadewych J.M. ter Hofstede
Publikováno v:
Annals of Pharmacotherapy, 34, pp. 465-470
Annual Review of Pharmacology and Toxicology, 34, 465. Annual Reviews Inc.
Annals of Pharmacotherapy, 34, 465-470
Annual Review of Pharmacology and Toxicology, 34, 465. Annual Reviews Inc.
Annals of Pharmacotherapy, 34, 465-470
OBJECTIVE: To report a case of antiretroviral therapy failure caused by an interaction between carbamazepine and indinavir. CASE SUMMARY: A 48-year-old HIV-positive white man was treated with antiretroviral triple therapy, consisting of indinavir, zi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad45a7823cfd3f0799f472625bc4662
https://hdl.handle.net/2066/143530
https://hdl.handle.net/2066/143530